(Q38543731)

4 September 2017

1 reference

title

A Dilemma in the Glycosaminoglycan-Based Therapy: Synthetic or Naturally Unique Molecules? (English)

1 reference

4 September 2017

1

Vitor H Pomin

1 reference

4 September 2017

publication date

7 July 2015

1 reference

Medicinal Research Reviews

4 September 2017

published in

1 reference

4 September 2017

volume

35

1 reference

4 September 2017

issue

6

1 reference

4 September 2017

page(s)

1195-1219

1 reference

Heparin and heparan sulfate: biosynthesis, structure and function

4 September 2017

cites work

1 reference

Heparin and heparan sulfate: structure and function

21 January 2018

1 reference

Recent advances in the structural biology of chondroitin sulfate and dermatan sulfate

21 January 2018

1 reference

MINI REVIEW Keratan sulfate: structure, biosynthesis, and function

21 January 2018

1 reference

Keratan sulfate: an up-to-date review

21 January 2018

1 reference

The structure of glycosaminoglycans and their interactions with proteins.

21 January 2018

1 reference

Therapeutic applications of glycosaminoglycans

21 January 2018

1 reference

Guide to anticoagulant therapy: Heparin : a statement for healthcare professionals from the American Heart Association

21 January 2018

1 reference

Initial treatment of venous thromboembolism

21 January 2018

1 reference

Hyaluronic acid hydrogels for biomedical applications

21 January 2018

1 reference

NMR chemical shifts in structural biology of glycosaminoglycans

21 January 2018

1 reference

Clinical experience with antithrombin III concentrate in treatment of congenital and acquired deficiency of antithrombin. The Antithrombin III Study Group

21 January 2018

1 reference

Structural and functional analyses of bovine and porcine intestinal heparins confirm they are different drugs

21 January 2018

1 reference

Contaminated heparin associated with adverse clinical events and activation of the contact system

21 January 2018

1 reference

Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events

21 January 2018

1 reference

New developments in the characterization of heparin and its impurities

21 January 2018

1 reference

Lessons learned from the contamination of heparin

21 January 2018

1 reference

The FDA and safety--beyond the heparin crisis

21 January 2018

1 reference

Carbohydrates as the next frontier in pharmaceutical research

21 January 2018

1 reference

Automated synthesis of oligosaccharides as a basis for drug discovery

21 January 2018

1 reference

Opportunities and challenges in synthetic oligosaccharide and glycoconjugate research

21 January 2018

1 reference

Acylsulfonamide safety-catch linker: promise and limitations for solid-phase oligosaccharide synthesis

21 January 2018

1 reference

A multifunctional anomeric linker for the chemoenzymatic synthesis of complex oligosaccharides

21 January 2018

1 reference

Enzymes in the synthesis of glycoconjugates

21 January 2018

1 reference

Recent chemical and enzymatic approaches to the synthesis of glycosaminoglycan oligosaccharides

21 January 2018

1 reference

Chemoenzymatic synthesis of glycosaminoglycans: re-creating, re-modeling and re-designing nature's longest or most complex carbohydrate chains

21 January 2018

1 reference

Chemoenzymatic synthesis of heparan sulfate and heparin

21 January 2018

1 reference

Synthesis of iduronic acid building blocks for the modular assembly of glycosaminoglycans

21 January 2018

1 reference

Modular synthesis of heparin oligosaccharides

21 January 2018

1 reference

A stereochemical surprise at the late stage of the synthesis of fully N-differentiated heparin oligosaccharides containing amino, acetamido, and N-sulfonate groups

21 January 2018

1 reference

Chemical approaches to define the structure-activity relationship of heparin-like glycosaminoglycans

21 January 2018

1 reference

Synthetic heparin derivatives as new anticoagulant drugs

21 January 2018

1 reference

Microarrays of synthetic heparin oligosaccharides.

21 January 2018

1 reference

Preparation and use of microarrays containing synthetic heparin oligosaccharides for the rapid analysis of heparin-protein interactions.

21 January 2018

1 reference

Potentiation of fibroblast growth factor activity by synthetic heparin oligosaccharide glycodendrimers

21 January 2018

1 reference

Solution structures of chemoenzymatically synthesized heparin and its precursors.

21 January 2018

1 reference

Design of biologically active heparan sulfate and heparin using an enzyme-based approach

21 January 2018

1 reference

Chemoenzymatic synthesis of heparin oligosaccharides with both anti-factor Xa and anti-factor IIa activities

21 January 2018

1 reference

Heparosan-derived heparan sulfate/heparin-like compounds: one kind of potential therapeutic agents

21 January 2018

1 reference

Synthetic di-sulfated iduronic acid attenuates asthmatic response by blocking T-cell recruitment to inflammatory sites

21 January 2018

1 reference

Modular synthesis of heparan sulfate oligosaccharides for structure-activity relationship studies.

21 January 2018

1 reference

Chemoenzymatic Design of Heparan Sulfate Oligosaccharides*

21 January 2018

1 reference

A synthetic heparan sulfate oligosaccharide library reveals the novel enzymatic action of D-glucosaminyl 3-O-sulfotransferase-3a

21 January 2018

1 reference

ELECTRON DETACHMENT DISSOCIATION OF SYNTHETIC HEPARAN SULFATE GLYCOSAMINOGLYCAN TETRASACCHARIDES VARYING IN DEGREE OF SULFATION AND HEXURONIC ACID STEREOCHEMISTRY.

21 January 2018

1 reference

Fluorous supported modular synthesis of heparan sulfate oligosaccharides

21 January 2018

1 reference

Chemoenzymatic synthesis and structural characterization of 2-O-sulfated glucuronic acid-containing heparan sulfate hexasaccharides

21 January 2018

1 reference

New glucuronic acid donors for the modular synthesis of heparan sulfate oligosaccharides

21 January 2018

1 reference

Fluorous-assisted chemoenzymatic synthesis of heparan sulfate oligosaccharides

21 January 2018

1 reference

Automated solid-phase synthesis of chondroitin sulfate glycosaminoglycans

21 January 2018

1 reference

Modular automated solid phase synthesis of dermatan sulfate oligosaccharides.

21 January 2018

1 reference

Isolation and characterization of hyaluronic acid from marine organisms

21 January 2018

1 reference

Chondroitin sulfate, hyaluronic acid and chitin/chitosan production using marine waste sources: characteristics, applications and eco-friendly processes: a review.

21 January 2018

1 reference

Unique extracellular matrix heparan sulfate from the bivalve Nodipecten nodosus (Linnaeus, 1758) safely inhibits arterial thrombosis after photochemically induced endothelial lesion

21 January 2018

1 reference

A non-hemorrhagic hybrid heparin/heparan sulfate with anticoagulant potential.

21 January 2018

1 reference

Glycosaminoglycans can influence fibroblast growth factor-2 mitogenicity without significant growth factor binding

21 January 2018

1 reference

Acharan sulfate, the new glycosaminoglycan from Achatina fulica Bowdich 1822. Structural heterogeneity, metabolic labeling and localization in the body, mucus and the organic shell matrix.

21 January 2018

1 reference

Antitumor properties of a new non-anticoagulant heparin analog from the mollusk Nodipecten nodosus: Effect on P-selectin, heparanase, metastasis and cellular recruitment

21 January 2018

1 reference

A heparin-like glycosaminoglycan from shrimp containing high levels of 3-O-sulfated D-glucosamine groups in an unusual trisaccharide sequence

21 January 2018

1 reference

Long duration of anticoagulant activity and protective effects of acharan sulfate in vivo

21 January 2018

1 reference

Chemical sulfonation and anticoagulant activity of acharan sulfate

21 January 2018

1 reference

Inhibition by acharan sulphate of angiogenesis in experimental inflammation models

21 January 2018

1 reference

Pharmacological activities of a new glycosaminoglycan, acharan sulfate isolated from the giant African snail Achatina fulica

21 January 2018

1 reference

Nucleolin: acharan sulfate-binding protein on the surface of cancer cells

21 January 2018

1 reference

Induction of nucleolin translocation by acharan sulfate in A549 human lung adenocarcinoma

21 January 2018

1 reference

Inhibition of Helicobacter pylori adhesion to Kato III cells by intact and low molecular weight acharan sulfate

21 January 2018

1 reference

Wound healing and antibacterial activities of chondroitin sulfate- and acharan sulfate-reduced silver nanoparticles

21 January 2018

1 reference

Activation of professional antigen presenting cells by acharan sulfate isolated from giant African snail, Achatina fulica

21 January 2018

1 reference

Holothurian fucosylated chondroitin sulfate

21 January 2018

1 reference

Different antithrombotic mechanisms among glycosaminoglycans revealed with a new fucosylated chondroitin sulfate from an echinoderm

21 January 2018

1 reference

Use of sulfated fucans as anticoagulant and antithrombotic agents: future perspectives

21 January 2018

1 reference

Venous and arterial thrombosis in rat models: dissociation of the antithrombotic effects of glycosaminoglycans

21 January 2018

1 reference

Depolymerized holothurian glycosaminoglycan (DHG), a novel alternative anticoagulant for hemodialysis, is safe and effective in a dog renal failure model

21 January 2018

1 reference

Fucosylated chondroitin sulfate attenuates renal fibrosis in animals submitted to unilateral ureteral obstruction: a P-selectin-mediated event?

21 January 2018

1 reference

Anti-HIV-1 activity and structure-activity-relationship study of a fucosylated glycosaminoglycan from an echinoderm by targeting the conserved CD4 induced epitope

21 January 2018

1 reference

The depolymerized fucosylated chondroitin sulfate from sea cucumber potently inhibits HIV replication via interfering with virus entry

21 January 2018

1 reference

Fucosylated chondroitin sulfate from Acaudina molpadioides improves hyperglycemia via activation of PKB/GLUT4 signaling in skeletal muscle of insulin resistant mice

21 January 2018

1 reference

Fucosylated chondroitin sulfate inhibits Plasmodium falciparum cytoadhesion and merozoite invasion.

21 January 2018

1 reference

The protective role of fucosylated chondroitin sulfate, a distinct glycosaminoglycan, in a murine model of streptozotocin-induced diabetic nephropathy

21 January 2018

1 reference

Sea, carbohydrates and clotting: a triad on the road of drug discovery

21 January 2018

1 reference

Sulfation pattern of the fucose branch is important for the anticoagulant and antithrombotic activities of fucosylated chondroitin sulfates.

21 January 2018

1 reference

Comparison of physicochemical characteristics and anticoagulant activities of polysaccharides from three sea cucumbers

21 January 2018

1 reference

Ascidian dermatan sulfates attenuate metastasis, inflammation and thrombosis by inhibition of P-selectin.

21 January 2018

1 reference

Towards a modular approach for heparin synthesis

21 January 2018

1 reference

New Set of Orthogonal Protecting Groups for the Modular Synthesis of Heparan Sulfate Fragments

21 January 2018

1 reference

Highly Sulfated Dermatan Sulfates from Ascidians

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/MED.21356

1 reference

release_62sqjntynrgmdihqz6omoaom4a

4 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/62sqjntynrgmdihqz6omoaom4a

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference